News

  • YOU ARE AT |
  • Home
  • News
  • Biosidus present at the BIO Internatinal Convention, June 6-9, San Francisco, U.S.A.

New Technologies/ view all

  • Transgenic animals to produce therapeutic proteins

    Biosidus has concluded is working on novel technologies for high-yield and cost-effective production of recombinant proteins for pharmaceutical applications.

    More
  • Gene Therapy

    Angiogenesis and muscle regeneration using the vascular endothelial growth factor.
    Vascular endothelial growth factor (VEGF) is a protein that stimulates the growth of blood vessels.

    More
  • Biodiversity

    White Genome Project
    Yet another groundbreaking initiative for Biosidus is the White Genome Project, which aims to isolate, identify and characterize Antarctic bacterial strains for further sequencing of the complete genome.

    More
SEPTEMBER 2016

Biosidus present at the BIO Internatinal Convention, June 6-9, San Francisco, U.S.A.

Biosidus S.A., exhibited at the BIO International Convention 2016 in San Francisco, US during June 6th-9th. This is the world's largest gathering of the biotechnology industry showcasing the many ways the biotechnology and life science industries work together to help heal, fuel and feed the world.

As in previous editions, Biosidus participated with its own stand and also took part of the show at the Argentina Pavillion.

More information: http://convention.bio.org/2015